19 drug(s) with this reaction
12,125 total reports
Drug Hypersensitivity has been reported as an adverse reaction across 19 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 12,125 adverse event reports mention drug hypersensitivity in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with drug hypersensitivity, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have drug hypersensitivity listed in their FDA adverse event reports, sorted by report count:
In addition to drug hypersensitivity, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
19 drug(s) manufactured by Haleon Us Holdings Llc have drug hypersensitivity listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
There are a combined 12,125 reports of drug hypersensitivity across 19 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.